Cosan SA (CSAN3M)
BOV
21 months median OS in amezalpat arm vs. 15 in control arm 50% (20/40) of patients on amezalpat arm remain in survival follow up 0.65 hazard ratio, maintained since 0.59 observed in primary...
BRISBANE, Calif., June 18, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-classi targeted and immune-mediated...
BRISBANE, Calif., June 07, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class1 targeted and immune-mediated...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
Symbol | Price | Vol. |
---|---|---|
HBSA3Hidrovias DO Brasil SA | R$ 3.55 (-1.39%) | 5.04M |
GGPS3GPS Participacoes e Empreendimentos S.A. | R$ 16.91 (-1.91%) | 3.49M |
LOGG3LOG Commercial Properties Participacoes SA | R$ 21.32 (0.09%) | 569.1k |
FRAS3Fras le Sa | R$ 18.98 (-1.86%) | 551.3k |
PLPL3Plano & Plano Desenvolvimento Imobiliario S.A. | R$ 11.35 (0.44%) | 543.6k |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.